Browsing Tag
Oragenics
3 posts
Why neuroinflammation and systemic inflammation are becoming central targets in traumatic brain injury research
Why are neuroinflammation and systemic inflammation becoming major targets in traumatic brain injury research? Explore the industry shift now.
How intranasal neurosteroids may change emergency care timing in mild traumatic brain injury
Can ONP-002 change concussion care timing? Discover how Oragenics, Inc. is targeting early intervention in mTBI treatment.
Oragenics, Lantern Bioworks forge partnership for replacement-therapy assets
In a landmark collaboration, Oragenics, Inc. (NYSE American: OGEN) and Lantern Bioworks have sealed a groundbreaking partnership through…